A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS–Cancer‐Associated thrombosis study

GT Gerotziafas, A Taher, H Abdel‐Razeq… - The …, 2017 - academic.oup.com
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.

GT Gerotziafas, A Taher, H Abdel-Razeq… - The …, 2017 - europepmc.org
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.

GT Gerotziafas, A Taher, H Abdel‐Razeq… - …, 2017 - search.ebscohost.com
Background. The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer-Associated Thrombosis Study

G Gerotziafas, A Taher, H Abdel-Razeq, E Aboelnazar… - Oncologist, 2017 - hal.science
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

[HTML][HTML] A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis …

GT Gerotziafas, A Taher, H Abdel‐Razeq… - The …, 2017 - ncbi.nlm.nih.gov
Background. The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

[PDF][PDF] A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis …

GT Gerotziafas, A Taher, H Abdel‐Razeq… - The …, 2017 - Wiley Online Library
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study

GT Gerotziafas, A Taher, H Abdel-Razeq… - The …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

[PDF][PDF] A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer-Associated Thrombosis …

GT GEROTZIAFAS, ALI TAHER, H ABDEL-RAZEQ… - pdfs.semanticscholar.org
Background. The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer-Associated Thrombosis Study

GT Gerotziafas, A Taher, H Abdel-Razeq… - The Oncologist, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The stratification of outpatients on chemotherapy for breast, colorectal, lung, and ovarian …

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study

GT Gerotziafas, A Taher, H Abdel-Razeq… - The …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …